Gynecologic Oncology Group

This study tested a combination of two drugs, ribociclib and letrozole, in 51 women whose low-grade serous ovarian, fallopian tube, or peritoneal cancer had come back. The goal was to see if the treatment could shrink tumors or stop them from growing. Participants took the drugs …

This study tests a combination of two drugs, abemaciclib and letrozole, in people with advanced or recurrent endometrioid endometrial cancer that cannot be cured by surgery or radiation. The main goal is to see how many participants have no cancer growth after 6 months of treatme…